Meyka Pro banner
Kamada Ltd.

Kamada Ltd. (KMDA) Stock Overview

Explore Kamada Ltd.’s financial performance, market position, analyst ratings, and future outlook.

KMDANASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$8.24
$0.22(2.74%)
U.S. Market opens in 62h 58m

Kamada Ltd. (KMDA)

Meyka AI Score

Z

Key Financials

Market Cap475.4M
P/E Ratio21.40
EPS (TTM)$0.38
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$7.02
3 Months$5.45
1 Year Target$8.84

KMDA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Kamada Ltd. (NASDAQ: KMDA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Kamada Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KMDA on the NASDAQ shows an RSI of 72.72, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $8.84 for the NASDAQ listing.

Key metrics behind Kamada Ltd.'s NASDAQ-traded stock include a P/E ratio of 21.40 and a market capitalization of 475.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of KMDA on the NASDAQ.

Price Performance (NASDAQ: KMDA)

1-Day Change
2.74%
5-Day Change
11.96%
1-Month Change
13.19%
3-Month Change
5.37%
6-Month Change
-6.36%
Year-to-Date (YTD) Change
16.71%
1-Year Change
16.88%
3-Year Change
47.67%
5-Year Change
55.18%
All-Time (Max) Change
-21.82%

Contact Information

972 8 940 6472
2 Holzman Street, Rehovot, HM, 7670402

Company Facts

4,620 Employees
IPO DateMay 31, 2013
CountryIL
Actively Trading

Frequently Asked Questions